The 3rd Transparency & Aggregate Spend Summit, held on June 3-4, 2024, in Philadelphia, focused on the latest challenges and solutions in HCP spend reporting compliance for the life sciences industry. Attendees delved into new state requirements, global transparency, and data analytics, with special attention to CMS audits. The speaking faculty included colleagues from Johnson & Johnson, Roche Diagnostics, and Takeda.
The event featured interactive breakout groups and expert-led sessions, fostering deep discussions on improving data capture and compliance processes. Key topics included strategies for managing state reporting requirements and leveraging data analytics for compliance efficiency. The summit provided a platform for professionals from pharmaceutical, biotech, and medical device sectors to share experiences and best practices, promoting a comprehensive understanding of transparency reporting requirements.
For those unable to attend in person, an On-Demand option is available, allowing participants to access all the conference content from anywhere at any time. This ensures broader accessibility to the valuable insights and discussions from the event.
Learn more today: https://dgevents.com/event/transparency-aggregate-spend-summit/
